Literature DB >> 17638703

Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.

Frank P Mockenhaupt1, Klaus Reither, Philipp Zanger, Felix Roepcke, Ina Danquah, Eiman Saad, Peter Ziniel, Stephen Y Dzisi, Marc Frempong, Patrick Agana-Nsiire, Felicia Amoo-Sakyi, Rowland Otchwemah, Jakob P Cramer, Sylvester D Anemana, Ekkehart Dietz, Ulrich Bienzle.   

Abstract

Morbidity and mortality from malaria remain unacceptably high among young children in sub-Saharan Africa. Intermittent preventive treatment in infancy (IPTi) involves the administration of antimalarials alongside routine vaccinations and might be an option in malaria control. In an area of intense, perennial malaria transmission in northern Ghana, 1,200 children received IPTi with sulfadoxine-pyrimethamine or placebo at approximately 3, 9, and 15 months of age. Children were followed up until 24 months of age to assess morbidity and adverse events. During the intervention period (3 to 18 months of age), IPTi reduced the incidences of malaria and severe anemia by 22.5% (95% confidence interval, 12 to 32%) and 23.6% (95% confidence interval, 4 to 39%), respectively, and reduced hospitalizations and episodes of asymptomatic parasitemia by one-third. Protection was pronounced in the first year of life and not discernible in the second. The malaria-protective effect was largely confined to a period of 1 month after sulfadoxine-pyrimethamine treatments. Following the intervention, protection against asymptomatic parasitemia persisted. In contrast, a significant rebound of severe malaria, predominantly severe malarial anemia, occurred among children having received IPTi. Although the treatment was generally well tolerated, one case of moderately severe skin reaction followed sulfadoxine-pyrimethamine treatment. IPTi reduces malaria and anemia in infants in northern Ghana. Extension of IPTi into the second year of life by administering a dose at 15 months of age provided no substantial benefit beyond a 1-month prophylactic effect. Although this simple intervention offers one of the few available malaria-preventive measures for regions where malaria is endemic, the observed rebound of severe malaria advises caution and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638703      PMCID: PMC2043181          DOI: 10.1128/AAC.00513-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection.

Authors:  H P Beck; I Felger; P Vounatsou; R Hirt; M Tanner; P Alonso; C Menendez
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

3.  Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

Authors:  D Schellenberg; C Menendez; E Kahigwa; J Aponte; J Vidal; M Tanner; H Mshinda; P Alonso
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

4.  Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial.

Authors:  David Schellenberg; Clara Menendez; John J Aponte; Elizeus Kahigwa; Marcel Tanner; Hassan Mshinda; Pedro Alonso
Journal:  Lancet       Date:  2005 Apr 23-29       Impact factor: 79.321

5.  A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.

Authors:  Frank P Mockenhaupt; Stephan Ehrhardt; Stephen Y Dzisi; J Teun Bousema; Nasstasja Wassilew; Jonas Schreiber; Sylvester D Anemana; Jakob P Cramer; Rowland N Otchwemah; Robert W Sauerwein; Teunis A Eggelte; Ulrich Bienzle
Journal:  Trop Med Int Health       Date:  2005-06       Impact factor: 2.622

Review 6.  Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

Authors:  Joel G Breman; Martin S Alilio; Anne Mills
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

7.  Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing.

Authors:  Dianne J Terlouw; Bernard L Nahlen; Jeanne M Courval; Simon K Kariuki; Oren S Rosenberg; Aggrey J Oloo; Margarette S Kolczak; William A Hawley; Altaf A Lal; Feiko O ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.

Authors:  Robin Kobbe; Christina Kreuzberg; Samuel Adjei; Benedicta Thompson; Iris Langefeld; Peter Apia Thompson; Harry Hoffman Abruquah; Benno Kreuels; Matilda Ayim; Wibke Busch; Florian Marks; Kwado Amoah; Ernest Opoku; Christian G Meyer; Ohene Adjei; Jürgen May
Journal:  Clin Infect Dis       Date:  2007-05-29       Impact factor: 9.079

9.  Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.

Authors:  Wendy Prudhomme O'Meara; David L Smith; F Ellis McKenzie
Journal:  PLoS Med       Date:  2006-04-04       Impact factor: 11.069

10.  Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.

Authors:  Neal Alexander; Colin Sutherland; Cally Roper; Badara Cissé; David Schellenberg
Journal:  Malar J       Date:  2007-01-22       Impact factor: 2.979

View more
  41 in total

1.  Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa.

Authors:  Ilona Carneiro; Lucy Smith; Amanda Ross; Arantxa Roca-Feltrer; Brian Greenwood; Joanna Armstrong Schellenberg; Thomas Smith; David Schellenberg
Journal:  Bull World Health Organ       Date:  2010-05-10       Impact factor: 9.408

Review 2.  Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.

Authors:  Ahmed Saadani Hassani; Barbara J Marston
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

Review 3.  Malaria: progress, perils, and prospects for eradication.

Authors:  Brian M Greenwood; David A Fidock; Dennis E Kyle; Stefan H I Kappe; Pedro L Alonso; Frank H Collins; Patrick E Duffy
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.

Authors:  Matthew Cairns; Roly Gosling; Ilona Carneiro; Samwel Gesase; Jacklin F Mosha; Ramadhan Hashim; Harparkash Kaur; Martha Lemnge; Frank W Mosha; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

5.  The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

Authors:  Lesong Conteh; Elisa Sicuri; Fatuma Manzi; Guy Hutton; Benson Obonyo; Fabrizio Tediosi; Prosper Biao; Paul Masika; Fred Matovu; Peter Otieno; Roly D Gosling; Mary Hamel; Frank O Odhiambo; Martin P Grobusch; Peter G Kremsner; Daniel Chandramohan; John J Aponte; Andrea Egan; David Schellenberg; Eusebio Macete; Laurence Slutsker; Robert D Newman; Pedro Alonso; Clara Menéndez; Marcel Tanner
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

6.  Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.

Authors:  Marjolein Gysels; Christopher Pell; Don P Mathanga; Philip Adongo; Frank Odhiambo; Roly Gosling; Patricia Akweongo; Rose Mwangi; George Okello; Peter Mangesho; Lawrence Slutsker; Peter G Kremsner; Martin P Grobusch; Mary J Hamel; Robert D Newman; Robert Pool
Journal:  Malar J       Date:  2009-08-10       Impact factor: 2.979

7.  Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.

Authors:  Frank O Odhiambo; Mary J Hamel; John Williamson; Kim Lindblade; Feiko O ter Kuile; Elizabeth Peterson; Peter Otieno; Simon Kariuki; John Vulule; Laurence Slutsker; Robert D Newman
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

Review 8.  Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.

Authors:  Vasee S Moorthy; Zarifah Reed; Peter G Smith
Journal:  Malar J       Date:  2009-02-10       Impact factor: 2.979

9.  The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.

Authors:  Ricardo Aguas; José M L Lourenço; M Gabriela M Gomes; Lisa J White
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

10.  Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.

Authors:  Alassane Dicko; Issaka Sagara; Abdoulaye A Djimdé; Sidy O Touré; Mariam Traore; Souleymane Dama; Abdoulbaki I Diallo; Amadou Barry; Mohamed Dicko; Oumar M Coulibaly; Christophe Rogier; Alexandra de Sousa; Ogobara K Doumbo
Journal:  Malar J       Date:  2010-01-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.